Safety and efficacy of PD-1 inhibitor combined with transarterial chemoembolization for intermediate-stage HCC

Journal for ImmunoTherapy of Cancer shared a post on X:

“New JITC article: Safety and efficacy of PD-1 inhibitor (sintilimab) combined with transarterial chemoembolization as the initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria.”

Safety and efficacy of PD-1 inhibitor (sintilimab) combined with transarterial chemoembolization as the initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria

Authors: Lixing Li, Xin Xu, Wentao Wang, Peiran Huang, Lei Yu, Zhenggang Ren, Jia Fan, Jian Zhou, Lan Zhang, Zheng Wang

Safety and efficacy of PD-1 inhibitor combined with transarterial chemoembolization for intermediate-stage HCC

Blog Posts

cancer Jia Fan Jian Zhou Journal for ImmunoTherapy of Cancer Lan Zhang Lei Yu Lixing Li OncoDaily Oncology Peiran Huang Wentao Wang Xin Xu Zheng Wang Zhenggang Ren